ArticleCancers2021

A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial.

Gian Maria Zaccaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.